RCKT
Rocket Pharmaceuticals Inc
NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY
$3.48
+0.00% today
Updated 2026-04-30
Market cap
$379.93M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$2 – $8
Volume
3.7M
Rocket Pharmaceuticals Inc (RCKT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-60.30%
ROA
-33.30%
Debt/equity
0.08x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-6.06M | — | — | — |
| 2013 | — | $-7.62M | — | — | — |
| 2014 | $0.00 | $-9.53M | — | — | — |
| 2015 | $0.00 | $-67.98M | — | — | — |
| 2016 | $0.00 | $-42.85M | — | — | — |
| 2017 | $0.00 | $-29.50M | — | — | — |
| 2018 | $0.00 | $-74.52M | — | — | — |
| 2019 | $0.00 | $-83.23M | — | — | — |
| 2020 | $0.00 | $-146.67M | — | — | — |
| 2021 | $0.00 | $-169.07M | — | — | — |
| 2022 | $0.00 | $-221.86M | — | — | — |
| 2023 | $0.00 | $-245.59M | — | — | — |
| 2024 | $0.00 | $-258.75M | — | — | — |
| 2025 | $0.00 | $-223.12M | — | — | — |